|
Aerocrine: UK clinical study demonstrates that asthma tests can identify non …
Fort Mills Times Aerocrine AB (OMX Nordic Exchange: AERO) announces that a clinical trial published in The American Journal of Respiratory and Critical Care Medicine shows that FeNO-testing is an excellent tool to identify patients that don't adhere to treatment. |
View full post on asthma – Google News